Eko Foundation Analysis Software with Transformers (EFAST) vs Us2.v1
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
EFAST aids clinicians in real-time detection of structural murmurs and atrial fibrillation during physical examinations using digital stethoscopes. In contrast, Us2.v1 offers fully automated AI analysis of echocardiography images, providing comprehensive structured reports for detailed cardiac assessment. While both leverage AI for cardiac diagnostics, they address different diagnostic modalities and stages of patient evaluation.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
EFAST by Eko Health is designed to assist clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation during routine exams, providing real-time cardiac insights. Us2.v1 by Us2.ai provides fully automated AI software for echocardiography analysis, generating comprehensive structured reports with measurements and disease detection in seconds.
EFAST utilizes heart sounds and electrocardiograms (ECGs) recorded using Eko digital stethoscopes for its real-time AI analysis during auscultation. Us2.v1 processes echocardiography images in DICOM format for automated analysis and report generation.
EFAST is designed for use across Cardiology, Family Medicine, and Internal Medicine specialties. Us2.v1 is primarily designed for the Cardiology specialty.
EFAST uses a subscription-based pricing model, specifically an Eko+ yearly membership, with a free trial included with stethoscope purchase. Us2.v1 operates on a volume-based pricing model, requiring contact for a quotation.
EFAST requires seamless integration with Eko digital stethoscopes, such as the CORE 500, for its real-time AI analysis. Us2.v1 is vendor agnostic and compatible with any ultrasound device, PACS, CVIS, or EMR, connecting to existing infrastructure.
EFAST detects structural murmurs associated with heart disease with 93% sensitivity and 91% specificity, and atrial fibrillation (AFib) with 95% sensitivity and 94% specificity. Us2.v1 provides comprehensive structured reports with measurements and disease detection, including automated detection of cardiac amyloidosis and pulmonary hypertension.
More Comparisons
Backers
Who funded each tool's parent company.